摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3;4,5-diisopropylene D-xylitol

中文名称
——
中文别名
——
英文名称
2,3;4,5-diisopropylene D-xylitol
英文别名
1,2:3,4-di-O-isopropylidene-D-arabinitol;2,3:4,5-di-O-isopropylidene-D-arabitol;[(4R,5R)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-1,3-dioxolan-4-yl]methanol
2,3;4,5-diisopropylene D-xylitol化学式
CAS
——
化学式
C11H20O5
mdl
——
分子量
232.277
InChiKey
FBIWGPWXTDOFQR-IWSPIJDZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    57.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3;4,5-diisopropylene D-xylitol咪唑 、 sodium iodide 、 作用下, 以 吡啶乙醇二氯甲烷丙酮 为溶剂, 反应 49.0h, 生成 (2R,3R)-3-O-tert-butyldiphenylsilyl-1,2-O-isopropylidene-4-pentene-1,2,3-triol
    参考文献:
    名称:
    Syntheses of two diastereoisomers of panaxytriol, a potent antitumor agent isolated from panax ginseng
    摘要:
    (3R, 9R, 10R) 和 (3R, 9S, 10S) 对映异构体 (2 和 3) 的PA3(panaxytriol)通过合成得到了,并确认了PA3的绝对构型为(3R, 9R, 10R)-heptadec-1-en-4,6-diyne-3,9,10-triol。 © 1999 Elsevier Science Ltd. 保留所有权利。
    DOI:
    10.1016/s0040-4020(99)00352-x
  • 作为产物:
    描述:
    5-o-tert-butyldiphenylsilyl-α,β-D-arabinofuranose 在 sodium tetrahydroborate 、 四丁基氟化铵对甲苯磺酸 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 7.5h, 生成 2,3;4,5-diisopropylene D-xylitol
    参考文献:
    名称:
    Structure–activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 3: Role of the length of alditol side chain
    摘要:
    Five homologs of a novel glycolipid acremomannolipin A (1a), the potential Ca2+ signal modulator isolated from Acremonium strictum, bearing alditols of different length (1g-1k) were synthesized by a stereoselective beta-mannosylation of appropriately protected mannosyl sulfoxide (2) with five alditols (1g: C2, 1h: C3, 1i: C4, 1j: C5 and 1k: C7 units), and their potential in modulating Ca2+ signaling were evaluated. Homologs with alditols of more than 4 carbons (1i, 1j and 1k) were equally or more potent than the parent compound (1a) regardless of the length of the alditol chain. Whereas activities of two homologs with shorter chains (1g and 1h) decreased to a considerable extent. The results indicated that the length of the alditol side chain was a crucial determinant for the potent calcium signal modulating activity. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.03.079
点击查看最新优质反应信息

文献信息

  • Ophthamological drugs
    申请人:Toone J. Eric
    公开号:US20060135609A1
    公开(公告)日:2006-06-22
    The present invention relates generally to ophthamological drugs. More specifically, the inventon relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.
    本发明一般涉及眼科药物。更具体地,本发明涉及一种修改(衍生化)眼科药物的方法,以增加它们通过角膜的渗透性。本发明还涉及根据本方法修改(衍生化)的药物,以及将其用于治疗与眼内压升高相关的疾病,特别是青光眼。
  • OPHTHAMOLOGICAL DRUGS
    申请人:Toone Eric J.
    公开号:US20090318542A1
    公开(公告)日:2009-12-24
    The present invention relates generally to ophthamological drugs. More specifically, the invention relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.
    本发明通常涉及眼科药物。更具体地说,本发明涉及一种改性(衍生化)眼科药物的方法,以增加它们穿过角膜的渗透性。本发明还涉及按照本方法改性(衍生化)的药物,以及将其用于治疗与眼内压升高有关的疾病,特别是青光眼。
  • ANTI-TUMOR AGENT
    申请人:Kinki University
    公开号:EP2716293B1
    公开(公告)日:2017-09-06
  • US8642644B2
    申请人:——
    公开号:US8642644B2
    公开(公告)日:2014-02-04
  • Structure–activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 3: Role of the length of alditol side chain
    作者:Nozomi Tsutsui、Genzoh Tanabe、Nao Morita、Yoshitomo Okayama、Ayako Kita、Reiko Sugiura、Osamu Muraoka
    DOI:10.1016/j.bmc.2015.03.079
    日期:2015.7
    Five homologs of a novel glycolipid acremomannolipin A (1a), the potential Ca2+ signal modulator isolated from Acremonium strictum, bearing alditols of different length (1g-1k) were synthesized by a stereoselective beta-mannosylation of appropriately protected mannosyl sulfoxide (2) with five alditols (1g: C2, 1h: C3, 1i: C4, 1j: C5 and 1k: C7 units), and their potential in modulating Ca2+ signaling were evaluated. Homologs with alditols of more than 4 carbons (1i, 1j and 1k) were equally or more potent than the parent compound (1a) regardless of the length of the alditol chain. Whereas activities of two homologs with shorter chains (1g and 1h) decreased to a considerable extent. The results indicated that the length of the alditol side chain was a crucial determinant for the potent calcium signal modulating activity. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多